Standout Papers
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels (1996)
- Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes (2007)
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (2013)
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus (2013)
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. (1990)
- The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI (2000)
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban (2001)
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein (1999)
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels (1998)
- Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials (2015)
- Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes (2004)
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions (2016)
- Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction (2000)
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction (1999)
- ACC/AHA guideline for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction (2002)
- A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease (2009)
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial (2009)
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events (2012)
- Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention (2007)
- Mechanism of Action of Calcium-Channel-Blocking Agents (1982)
- Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes (2002)
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial (2014)
- Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes (2005)
- Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy (2006)
- Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes (2005)
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 (2008)
- Aortic Stenosis (1968)
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel (2009)
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction (2016)
- Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials (2015)
- Risk factors for sudden death after acute myocardial infarction: Two-year follow-up (1984)
- Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? (1980)
- Coronary-Artery Spasm (1978)
- Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction (2015)
- Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors (2020)
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial (2015)
- Gliflozins in the Management of Cardiovascular Disease (2022)
- Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis (2021)
- Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure (2023)
- Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations (2024)
Immediate Impact
1 by Nobel laureates 11 from Science/Nature 256 standout
Citing Papers
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
2020 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Works of Eugene Braunwald being referenced
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
2020 Standout
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
2014 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eugene Braunwald | 49596 | 29906 | 11807 | 12024 | 687 | 75.0k | |
| Christopher P. Cannon | 37120 | 27182 | 10557 | 13675 | 869 | 65.6k | |
| Philippe Gabríel Steg | 54884 | 29325 | 9926 | 9558 | 1.1k | 74.8k | |
| Marc S. Sabatine | 27026 | 22026 | 5004 | 12790 | 499 | 49.0k | |
| Eugene Braunwald | 41820 | 18050 | 12184 | 4791 | 444 | 56.1k | |
| Marc A. Pfeffer | 62884 | 25888 | 9146 | 17255 | 593 | 94.5k | |
| Deepak L. Bhatt | 55509 | 38853 | 7586 | 22590 | 2.0k | 103.4k | |
| Emelia J. Benjamin | 68687 | 11568 | 9327 | 8206 | 766 | 98.8k | |
| Valentı́n Fuster | 52301 | 33107 | 22414 | 6421 | 1.3k | 98.0k | |
| Sabina A. Murphy | 29083 | 17306 | 6173 | 7761 | 482 | 42.0k | |
| Gregg C. Fonarow | 76391 | 17156 | 6508 | 9723 | 1.8k | 109.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...